Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LORD

Showing results (311-320 of 596) with videos related to

Pageof 60
Sort By:
British Journal of Urology|August 1, 1988
Prolonged erections following intracorporeal injection of medications to overcome impotenceG R Watters, E J Keogh, C J Carati, et al.
Breast (Edinburgh, Scotland)|July 15, 2018
Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancerAmira Elmadahm, Sarah J Lord, H Malcolm Hudson, et al.
Australasian Radiology|May 1, 1989
The role of dynamic corpora cavernosography in the management of impotenceJ J Glancy, Z S Wisniewski, C M Earle, et al.
BMJ Open|February 3, 2019
Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocolSarah J Lord, Belinda E Kiely, Sallie-Anne Pearson, et al.
BMC Pregnancy and Childbirth|January 8, 2020
Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation studyZiad T A Al-Rubaie, H Malcolm Hudson, Gregory Jenkins, et al.
The Journal of Organic Chemistry|August 19, 2020
Synthesis and Photochromism of Novel Pyridyl-Substituted NaphthopyransOrlando D C C de Azevedo, Paul I P Elliott, Christopher D Gabbutt, et al.
Plos Genetics|February 16, 2021
Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cellsAndrey A Parkhitko, Arashdeep Singh, Sharon Hsieh, et al.
BMJ Open|January 26, 2017
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohortBenjamin Daniels, Sarah J Lord, Belinda E Kiely, et al.
Oncogene|June 20, 2018
Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancerRachel Brough, Aditi Gulati, Syed Haider, et al.
Nature Communications|May 24, 2018
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targetsDragomir B Krastev, Stephen J Pettitt, James Campbell, et al.
Pageof 60

Showing results (311-320 of 596) with videos related to

Sort By:
Pageof 60
British Journal of Urology|August 1, 1988
Prolonged erections following intracorporeal injection of medications to overcome impotenceG R Watters, E J Keogh, C J Carati, et al.
Breast (Edinburgh, Scotland)|July 15, 2018
Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancerAmira Elmadahm, Sarah J Lord, H Malcolm Hudson, et al.
Australasian Radiology|May 1, 1989
The role of dynamic corpora cavernosography in the management of impotenceJ J Glancy, Z S Wisniewski, C M Earle, et al.
BMJ Open|February 3, 2019
Metastatic breast cancer incidence, site and survival in Australia, 2001-2016: a population-based health record linkage study protocolSarah J Lord, Belinda E Kiely, Sallie-Anne Pearson, et al.
BMC Pregnancy and Childbirth|January 8, 2020
Prediction of pre-eclampsia in nulliparous women using routinely collected maternal characteristics: a model development and validation studyZiad T A Al-Rubaie, H Malcolm Hudson, Gregory Jenkins, et al.
The Journal of Organic Chemistry|August 19, 2020
Synthesis and Photochromism of Novel Pyridyl-Substituted NaphthopyransOrlando D C C de Azevedo, Paul I P Elliott, Christopher D Gabbutt, et al.
Plos Genetics|February 16, 2021
Cross-species identification of PIP5K1-, splicing- and ubiquitin-related pathways as potential targets for RB1-deficient cellsAndrey A Parkhitko, Arashdeep Singh, Sharon Hsieh, et al.
BMJ Open|January 26, 2017
Use and outcomes of targeted therapies in early and metastatic HER2-positive breast cancer in Australia: protocol detailing observations in a whole of population cohortBenjamin Daniels, Sarah J Lord, Belinda E Kiely, et al.
Oncogene|June 20, 2018
Identification of highly penetrant Rb-related synthetic lethal interactions in triple negative breast cancerRachel Brough, Aditi Gulati, Syed Haider, et al.
Nature Communications|May 24, 2018
Coupling bimolecular PARylation biosensors with genetic screens to identify PARylation targetsDragomir B Krastev, Stephen J Pettitt, James Campbell, et al.
Pageof 60